Using Genomics to Improve Pigmented Lesion Management & Health Outcomes

Main Article Content

Clay Cockerell
University of Texas Southwestern Medical Center, Dallas, TX, USA

Roger Ceilley
University of Iowa

Mark Lebwohl
Icahn School of Medicine at Mount Sinai Hospital

Darrell Rigel
Icahn School of Medicine at Mount Sinai Hospital

Keywords

genomics, biopsy, access to care

Abstract

Abstract not available. 

References

1. Anderson AM, Matsumoto M, Saul MI, Secrest AM, Ferris LK. Accuracy of Skin Cancer Diagnosis by Physician Assistants Compared With Dermatologists in a Large Health Care System. JAMA Dermatol. May 1 2018;154(5):569-573. doi:10.1001/jamadermatol.2018.0212

2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians. 2021;71(1):7-33. doi:https://doi.org/10.3322/caac.21654

3. Gerami P, Yao Z, Polsky D, et al. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma. J Am Acad Dermatol. Jan 2017;76(1):114-120 e2. doi:10.1016/j.jaad.2016.07.038

4. Data on file. DermTech, Inc. La Jolla, California.

5. Hornberger J, Siegel DM. Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions. JAMA Dermatol. Sep 1 2018;154(9):1025-1031. doi:10.1001/jamadermatol.2018.1764

6. Skelsey M, Brouha B, Rock J, et al. Non-Invasive Detection of Genomic Atypia Increases Real-World NPV and PPV of the Melanoma Diagnostic Pathway and Reduces Biopsy Burden. SKIN The Journal of Cutaneous Medicine. 2021;5(5):512-523.

7. Lott JP, Boudreau DM, Barnhill RL, et al. Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing. JAMA Dermatol. Jan 1 2018;154(1):24-29. doi:10.1001/jamadermatol.2017.4060

Article Sidebar

PDF
Published
Mar 4, 2022
DOI https://doi.org/10.25251/skin.6.2.1

Article Details

How to Cite
Cockerell, C., Ceilley, R., Lebwohl, M., & Rigel, D. (2022). Using Genomics to Improve Pigmented Lesion Management & Health Outcomes. SKIN The Journal of Cutaneous Medicine, 6(2), 87–89. https://doi.org/10.25251/skin.6.2.1
Issue
Vol. 6 No. 2 (2022): March Issue and Poster Presentations (FC PANP 21 and WC 22 Dermatology Conferences®)
Section
Editorials
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

<< < 5 6 7 8 9 10 11 12 13 14 > >>